This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The expansion includes a larger technical and service team and increased local procurement
The state-of-the-art facility is expected to be commissioned over the next three years
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
The Signals Xynthetica solution brings AI-driven in-silico generation, predictive modeling, and experimental validation into a single, governed environment
Hansoh Pharma will receive an upfront payment in the low double-digit millions
If approved, CUTX-101 will be the first and only FDA approved treatment available for Menkes disease
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Subscribe To Our Newsletter & Stay Updated
